Urolithiasis in Germany: Trends from the National DRG Database.
Endourology
Epidemiology
Public health
Urolithiasis
Journal
Urologia internationalis
ISSN: 1423-0399
Titre abrégé: Urol Int
Pays: Switzerland
ID NLM: 0417373
Informations de publication
Date de publication:
2022
2022
Historique:
received:
29
04
2021
accepted:
13
10
2021
pubmed:
10
12
2021
medline:
7
6
2022
entrez:
9
12
2021
Statut:
ppublish
Résumé
Urolithiasis is a common disease leading to a high socioeconomic burden due to treatment costs and sickness leave. The aim of this study was to evaluate recent trends in the incidence of urolithiasis in Germany and in the use of therapeutic interventions. Treatment data for all in-patient hospital episodes for urolithiasis between 2005 and 2016 were extracted from the national DRG statistics at DESTATIS and analysed with regard to the corresponding procedures according to the OPS code. Incidence for urolithiasis was stable at around 120,000 cases per year during the observation period with a male:female ratio of 2:1. Rising numbers were noted for patients >80 years. Nevertheless, the number of coded procedures rose significantly with a marked disproportionate transition from extracorporeal shock wave lithotripsy towards ureterorenoscopy. Percutaneous nephrolithotomy was performed more frequently on a smaller scale. While the global incidence of urolithiasis is still rising, Germany, as other Western countries, has reached a plateau. There is a remarkable trend towards invasive treatment of even asymptomatic kidney stones. Besides the effects on individual patients with increased risk for complications, this results in a higher monetary burden to the health care system and society.
Identifiants
pubmed: 34883491
pii: 000520372
doi: 10.1159/000520372
pmc: PMC9248299
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
589-595Informations de copyright
© 2021 The Author(s). Published by S. Karger AG, Basel.
Références
Urologe A. 2014 Dec;53(12):1764-71
pubmed: 25412912
Curr Opin Urol. 2019 Mar;29(2):81-88
pubmed: 30418258
Urol Int. 2021;105(3-4):240-246
pubmed: 33486481
Curr Urol Rep. 2020 Mar 24;21(4):16
pubmed: 32211969
J Endourol. 2021 Jul;35(7):985-990
pubmed: 32962439
Dtsch Arztebl Int. 2012 Dec;109(51-52):885-92
pubmed: 23372612
Z Evid Fortbild Qual Gesundhwes. 2016 Oct;115-116:33-48
pubmed: 27837958
Curr Urol Rep. 2020 Nov 28;22(1):1
pubmed: 33247785
Urology. 2019 Feb;124:52-56
pubmed: 30391680
Eur Urol. 2012 Jul;62(1):160-5
pubmed: 22498635
Can J Urol. 2015 Feb;22(1):7627-34
pubmed: 25694010
J Endourol. 2021 Jul;35(7):961-966
pubmed: 33138642
BJU Int. 2013 Jul;112(2):224-30
pubmed: 23480795
BJU Int. 2016 Nov;118(5):785-789
pubmed: 27128735
BMC Gastroenterol. 2019 Sep 3;19(1):160
pubmed: 31481009
Eur Urol Focus. 2020 Jul 15;6(4):752-761
pubmed: 31085062
Urolithiasis. 2021 Jun;49(3):219-226
pubmed: 32926195
Kidney Int. 2013 Jan;83(1):146-52
pubmed: 22992468
Cochrane Database Syst Rev. 2014 Nov 24;(11):CD007044
pubmed: 25418417
Arab J Urol. 2012 Sep;10(3):265-72
pubmed: 26558035
Urology. 2014 Nov;84(5):1030-3
pubmed: 25201150
BJU Int. 2014 Mar;113(3):476-83
pubmed: 24053734
Urol Int. 2019;103(3):326-330
pubmed: 31394535
Curr Urol Rep. 2018 Mar 17;19(5):29
pubmed: 29550897
Int J Urol. 2019 Oct;26(10):1007-1008
pubmed: 31257649
Arch Ital Urol Androl. 2014 Jun 30;86(2):99-102
pubmed: 25017588
Urolithiasis. 2021 Feb;49(1):27-39
pubmed: 32870387
J Urol. 2013 Jun;189(6):2158-63
pubmed: 23313204
Lancet. 1980 Dec 13;2(8207):1265-8
pubmed: 6108446